SCOPE 2023

Double win for StudyKIK's oncology and cash apps helping trial patients

By Liza Laws

- Last updated on GMT

Double win for StudyKIK's oncology and cash apps

Related tags Technology Clinical trial Clinical research Patient centricity patient engagement

Year on year, the SCOPE summit brings thousands of people working in the pharma field together and the last one attracted more than 2,300 leaders in clinical operations and research.

It is also a place where work is recognized and awards are won and in the case of StudyKIK, they came away from last month’s event with two awards. Explaining what is so special about their apps, we spoke to the company’s product marketing manager, Kristin Ziagura.

Winning the Participant Engagement Award, she explained how their Oncology Study App works.

“The development of this app was rooted in feedback from real patients who have participated in complex trials.  To address the unique challenges faced by patients in the cell and gene therapy space, our application includes features that simplify study participation and provide educational support, to ensure a rewarding study journey while promoting a better sense of patient empowerment and control.”

She said these trials can be complicated, and that their application streamlines insights for patient ease.  Patients can monitor their trial progress from the moment their cells arrive to the lab, allowing them to prepare for next steps in treatment pathway.  Educational tools, FAQs and useful information with simple, patient-centric explanations keep patients informed about each stage and what to expect. 

Patients can access all their important study information in one convenient place. 

She added: “Uniquely, our application provides the ability to connect a patient’s support network which facilitates the participation of caregivers in the app, enabling them to receive the same important information as the patient during active treatment including dosage and appointment reminders.”

Their StudyCash app won Best of Show and offers a convenient, secure system that allows clinical trial participants around the world to ask for payment for their study-related activities. Patients can submit payment requests in a few easy steps from anywhere which makes accessibility and connection for patients around the world. There is no fee for patients so making, collecting, and tracking payments is as easy as it can be taking nothing away from the patient.

Asked exactly what this meant to the company, Ziagura added: “The patient experience is at the heart of everything we do.  That’s why we’re thrilled to have been recognized not once, but twice for our dedication to creating innovative, patient-centered technologies that make a positive impact in the clinical research industry. 

“Being honored in this way is a testament to the hard work and dedication of our team.  We’re focused on creating thoughtful products that help make the clinical trial journey smoother, more transparent, and less intimidating for participants.  It’s an honor to see our efforts being recognized by some of the industry’s most respected thought leaders at an event as prestigious as SCOPE.”

She said the recognition fuelled StudyKIKs mission to continue to push the boundaries of what’s possible ‘so that we can create a better future for patients and clinical researchers alike’. 

With regards to the industry the company believes these technologies help to prioritize the needs of patients, which is essential to the effective conduct of clinical research.  By improving the patient experience, it said, they can help to increase levels of patient engagement and retention, which in turn can help to improve the accuracy of research results. 

Ziagura added: “Our technologies help address some key challenges facing the clinical research industry, such as recruitment and retention of study participants.  By creating a better experience for participants and site teams alike, these technologies can help to reduce the burden and encourage more people to participate in clinical research.”  

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers